Show simple item record

dc.contributor.authorMurray, C
dc.contributor.authorFearon, C
dc.contributor.authorDockery, M
dc.contributor.authorMoran, D
dc.contributor.authorHeffernan, E
dc.contributor.authorFitzgerald, O
dc.contributor.authorVeale, D.J
dc.contributor.authorHarty, L
dc.date.accessioned2018-10-16T11:45:10Z
dc.date.available2018-10-16T11:45:10Z
dc.date.issued2018-10
dc.identifier.urihttp://hdl.handle.net/10147/623872
dc.description.abstractRecent studies have suggested gender-specific differences with respect to both baseline disease activity and severity in ankylosing spondylitis (AS). Tumour necrosis factor inhibitors (TNFi) have shown significant benefit in AS but there may be gender-specific differences regarding responses to TNFi therapy.en_US
dc.language.isoenen_US
dc.publisherIrish Medical Journalen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectARTHRITISen_US
dc.subjectGENDERen_US
dc.subject.otherAnkylosing Spondylitisen_US
dc.titleAnkylosing Spondylitis Response to TNF Inhibition Is Gender Specific: A 6-Year Cohort Studyen_US
dc.typeArticleen_US
dc.contributor.departmentSt. Vincent's University Hospitalen_US
dc.identifier.journalIrish Medical Journalen_US
dc.description.fundingNo fundingen_US
dc.description.provinceLeinsteren_US
dc.description.peer-reviewpeer-reviewen_US
refterms.dateFOA2018-10-16T11:45:10Z


Files in this item

Thumbnail
Name:
art3.htm
Size:
44.53Kb
Format:
HTML
Description:
Main Article

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States